These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 31793218)
1. EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma. Eladl AE; Shimada K; Suzuki Y; Takahara T; Kato S; Kohno K; Elsayed AA; Wu CC; Tokunaga T; Kinoshita T; Sakata-Yanagimoto M; Nakamura S; Satou A Cancer Med; 2020 Jan; 9(2):678-688. PubMed ID: 31793218 [TBL] [Abstract][Full Text] [Related]
2. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group. Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W; Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous angioimmunoblastic T-cell lymphoma: Epstein-Barr virus positivity and its effects on clinicopathologic features. Lee WJ; Won KH; Choi JW; Won CH; Chang SE; Choi JH; Lee MW J Am Acad Dermatol; 2019 Oct; 81(4):989-997. PubMed ID: 30240776 [TBL] [Abstract][Full Text] [Related]
4. [Expression and Clinical Pathological Significance of EBER, PTEN and VEGF in Angioimmunoblastic T-Cell Lymphoma]. Wang F; Zhang GH; Ding KY; Liu L; Weng HY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):663-8. PubMed ID: 26117013 [TBL] [Abstract][Full Text] [Related]
5. The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH. Liang JH; Lu L; Zhu HY; Li W; Fan L; Li JY; Xu W Cancer Res Treat; 2019 Jan; 51(1):150-157. PubMed ID: 29621877 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease. Takeuchi M; Sato Y; Yasui H; Ozawa H; Ohno K; Takata K; Gion Y; Orita Y; Tachibana T; Itoh T; Asano N; Nakamura S; Swerdlow SH; Yoshino T Am J Surg Pathol; 2014 Jul; 38(7):946-55. PubMed ID: 24705309 [TBL] [Abstract][Full Text] [Related]
7. Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene. Liang PI; Chang ST; Lin MY; Hsieh YC; Chu PY; Chen CJ; Lin KJ; Jung YC; Hwang WS; Huang WT; Chang WC; Ye H; Chuang SS Int J Clin Exp Pathol; 2014; 7(9):6097-107. PubMed ID: 25337257 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929 [TBL] [Abstract][Full Text] [Related]
9. The clinicopathological characteristics of C-MYC protein in angioimmunoblastic T-cell lymphoma. Peng Y; Yan H; Wang J; Zhang M; He J Acta Biochim Pol; 2022 Jul; 69(3):559-565. PubMed ID: 35878052 [TBL] [Abstract][Full Text] [Related]
10. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature. Yang QX; Pei XJ; Tian XY; Li Y; Li Z Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas. Chen YP; Jones D; Chen TY; Chang KC Leuk Lymphoma; 2014 Sep; 55(9):2038-47. PubMed ID: 24180328 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus infection, drug resistance and prognosis in Korean T- and NK-cell lymphomas. Jung CK; Lee KY; Kim Y; Han K; Shim SI; Kim BK; Kang CS Pathol Int; 2001 May; 51(5):355-63. PubMed ID: 11422793 [TBL] [Abstract][Full Text] [Related]
13. [Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma]. Shi YF; Wang HJ; Liu WP; Mi L; Long MP; Liu YF; Lai YM; Zhou LX; Diao XT; Li XH Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):521-529. PubMed ID: 37291929 [TBL] [Abstract][Full Text] [Related]
14. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Attygalle A; Al-Jehani R; Diss TC; Munson P; Liu H; Du MQ; Isaacson PG; Dogan A Blood; 2002 Jan; 99(2):627-33. PubMed ID: 11781247 [TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological features of angioimmunoblastic T-cell lymphoma pattern Ⅰ]. Lu HD; Xie JL; Zhang LN; Zheng YY; Zhou XG Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):856-860. PubMed ID: 36097902 [No Abstract] [Full Text] [Related]
16. [Angioimmunoblastic lymphadenopathy and angioimmunoblastic T-cell lymphoma]. Li T; Gao D; Zhang B Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):99-101. PubMed ID: 9206215 [TBL] [Abstract][Full Text] [Related]
17. Development of a Novel Clinical Prognostic Model for Patients With Angioimmunoblastic T-Cell Lymphoma. Huang C; Zhang H; Gao Y; Diao L; Liu L Technol Cancer Res Treat; 2020; 19():1533033820964231. PubMed ID: 33073702 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma. Okamoto A; Yanada M; Miura H; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Yoshikawa T; Mizoguchi Y; Nakamura S; Okamoto M; Emi N Cancer Sci; 2015 Nov; 106(11):1576-81. PubMed ID: 26353084 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus-Induced Cutaneous Diffuse Large B-Cell Lymphoma in a Patient With Angioimmunoblastic T-Cell Lymphoma. Poon F; Ieremia E; Collins G; Matin RN Am J Dermatopathol; 2019 Dec; 41(12):927-930. PubMed ID: 31599749 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus load correlating with clinical manifestation and treatment response in a patient with angioimmunoblastic T-cell lymphoma. Battegay M; Berger C; Rochlitz C; Hurwitz N; Hirsch HH; De Geyter C; Haque T; Nadal D Antivir Ther; 2004 Jun; 9(3):453-9. PubMed ID: 15259909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]